Abstract:Research progress into mechanisms of the anaerobe Clostridium perfringens and associated diseases has been frustrated by the lack of reliable infection models. Wax moth larvae (Galleria mellonella) have emerged as a viable alternative to other models of infection since they are economic, survive at 37°C and require no specialist equipment. This study aims to establish to what extent G. mellonella larvae can be used to study the virulence of C. perfringens strains and its suitability for studying novel treatment strategies by an improved time-lapse approach to data collection. Mortality and morbidity rates of larvae challenged with 105 CFU of C. perfringens isolates from various sources were observed over 72 h and dose response data obtained. Phenoloxidase enzyme activity was investigated as a marker for immune response and tissue burden assessed by histopathological techniques. Results demonstrate that C. perfringens is pathogenic toward G. mellonella although potency varies dramatically between C. perfringens isolates and the reference strain ATCC 13124 was shown to be avirulent. Infection with C. perfringens strains activated the melanisation pathway resulting in melanin deposition but no increase in enzyme activity was observed. Efficacy of antibiotic therapy (penicillin G, bacitracin, neomycin, and tetracycline) administered parenterally to some extent correlates with that of in vitro analysis. The findings suggest G. mellonella might be a useful in vivo model of infection and convenient as a pre-screening assay for virulence of C. perfringens strains or as a simple, cheap and rapid in vivo assay in the first stage development of novel therapeutics against anaerobes.HIGHLIGHTS –Potential novel in vivo model for the study of Clostridium perfringens infection. –Novel time-lapse approach to data collection. –First report of the pathogenicity of C. perfringens toward G. mellonella. –First report of the efficacy of antibiotic therapy in response to C. perfringens infection in G. mellonella.

Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing

Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future

Galleria mellonella as a Good Model to Study Acinetobacter baumannii Pathogenesis

A powerful in vivo alternative model in scientific research: Galleria mellonella

Galleria mellonella as an Antimicrobial Screening Model

Galleria mellonella as a Model for the Study of Fungal Pathogens: Advantages and Disadvantages

Optimization of Experimental Infection of the Animal Model Galleria mellonella Linnaeus 1758 (Lepidoptera: Pyralidae) with the Gram-Positive Bacterium Micrococcus luteus

Galleria mellonella Infection Model Identifies Both High and Low Lethality of Clostridium perfringens Toxigenic Strains and Their Response to Antimicrobials

Immunophenotyping of hemocytes from infected Galleria mellonella larvae as an innovative tool for immune profiling, infection studies and drug screening

Characterising phagocytes and measuring phagocytosis from live Galleria mellonella larvae

The dynamics of Staphylococcal infection and their treatment with antibiotics and bacteriophage in the Galleria mellonella model system

Galleria mellonella as an infection model for the virulent Mycobacterium tuberculosis H37Rv

Galleria mellonella Model of Coccidioidomycosis for Drug Susceptibility Tests and Virulence Factor Identification

Monitoring Gene Expression during a Galleria mellonella Bacterial Infection

An ELISA-based method for Galleria mellonella apolipophorin-III quantification

Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model

A novel Galleria mellonella experimental model for zoonotic pathogen Brucella

Applications of Invertebrate Animal Models to Dimorphic Fungal Infections

A Silkworm Infection Model for In Vivo Study of Glycopeptide Antibiotics

Galleria mellonella larvae as an alternative model to determine the pathogenicity of avian pathogenic Escherichia coli